Covered recipient · General Payments record
ROBERT A MILLS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,190.62
- Reported across 139 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $317.82 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Antares Pharma, Inc. | $93.85 | 4 |
| Ascensia Diabetes Care US Inc. | $37.01 | 2 |
| DEXCOM, INC. | $28.98 | 1 |
| JAZZ PHARMACEUTICALS INC. | $28.06 | 1 |
| Abbott Laboratories | $27.03 | 1 |
| Novo Nordisk AS | $23.73 | 1 |
| ABBVIE INC. | $23.49 | 1 |
| Medtronic, Inc. | $19.91 | 1 |
| Lilly USA, LLC | $19.32 | 1 |
| Xeris Pharmaceuticals, Inc. | $16.44 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $27.03 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124882933 | CMS |
| ABBVIE INC. | $23.49 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105040917 | CMS |
| Antares Pharma, Inc. | $20.19 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146474154 | CMS |
| Antares Pharma, Inc. | $32.38 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146474159 | CMS |
| Antares Pharma, Inc. | $20.64 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146474163 | CMS |
| Antares Pharma, Inc. | $20.64 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146474167 | CMS |
| Ascensia Diabetes Care Us Inc. | $19.31 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089087628 | CMS |
| Ascensia Diabetes Care Us Inc. | $17.70 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089087626 | CMS |
| Dexcom, Inc. | $28.98 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153331641 | CMS |
| JAZZ PHARMACEUTICALS INC. | $28.06 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150202920 | CMS |
| Lilly USA, LLC | $19.32 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135355180 | CMS |
| Medtronic, Inc. | $19.91 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117096184 | CMS |
| Novo Nordisk Inc | $23.73 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097378742 | CMS |
| Xeris Pharmaceuticals, Inc. | $16.44 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144610964 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.